MacroGenics
MGNX
#8690
Rank
โ‚น25.28 B
Marketcap
โ‚น396.94
Share price
0.24%
Change (1 day)
178.13%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น134.65

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น146.70. In 2025 the company made an earnings per share (EPS) of -โ‚น113.14 a decrease over its 2024 EPS that were of -โ‚น102.59.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น134.6519.01%
2025-โ‚น113.1410.28%
2024-โ‚น102.59613.33%
2023-โ‚น14.38-92.31%
2022-โ‚น186.97-42.14%
2021-โ‚น323.1236.44%
2020-โ‚น236.82-21.84%
2019-โ‚น302.98-24.58%
2018-โ‚น401.74675.93%
2017-โ‚น51.78-68.05%
2016-โ‚น162.04168.25%
2015-โ‚น60.40-55%
2014-โ‚น134.233400%
2013-โ‚น3.84-108.68%
2012โ‚น44.2024.49%
2011โ‚น35.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.60-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,706-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,388-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น711.43-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.76-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น341.33-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น219.57 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA